TY - JOUR
T1 - LIS1 functions in normal development and disease
AU - Reiner, Orly
AU - Sapir, Tamar
N1 - Israel Science Foundation [47/10]; Minerva foundation; Federal German Ministry for Education and Research; Chief Scientist Office at the Israeli Ministry of Health [IMOS 3-00000-6785]; Fritz-Thyseen Foundation [Az. 10.11.2.161]; Benoziyo Center for Neurological Diseases; Kekst Family Center for Medical Genetics; David and Fela Shapell Family Center for Genetic Disorders ResearchWe thank Dr Samara Reck-Peterson for critical reading of this manuscript. OR is an incumbent of the Berstein-Mason professorial chair of Neurochemistry. Our research has been supported in part by the Israel Science Foundation (grant no. 47/10), Minerva foundation with funding from the Federal German Ministry for Education and Research, a grant from the Chief Scientist Office at the Israeli Ministry of Health, under the frame of ERA-Net NEURON (DISCover, IMOS 3-00000-6785), the Fritz-Thyseen Foundation (grant Az. 10.11.2.161), the Benoziyo Center for Neurological Diseases, the Kekst Family Center for Medical Genetics and the David and Fela Shapell Family Center for Genetic Disorders Research.
PY - 2013/12
Y1 - 2013/12
N2 - LIS1, the first gene to be identified as involved in a neuronal migration disease, is a dosage-sensitive gene whose proper levels are required for multiple aspects of cortical development. Deletions in LIS1 result in a severe brain malformation, known as lissencephaly, whereas duplications delay brain development. LIS1 affects the proliferation of progenitors, spindle orientation and interkinetic nuclear movement in the ventricular zone, as well as nucleokinesis and migration of neurons. LIS1 regulatory interaction with the minus end directed molecular motor cytoplasmic dynein is the key for understanding its complex cellular functions. LIS1-dynein interaction decreases the average velocity of the molecular motor in vitro, shows more complex effects in vivo, and may be of importance in high-load transport especially in neurons.
AB - LIS1, the first gene to be identified as involved in a neuronal migration disease, is a dosage-sensitive gene whose proper levels are required for multiple aspects of cortical development. Deletions in LIS1 result in a severe brain malformation, known as lissencephaly, whereas duplications delay brain development. LIS1 affects the proliferation of progenitors, spindle orientation and interkinetic nuclear movement in the ventricular zone, as well as nucleokinesis and migration of neurons. LIS1 regulatory interaction with the minus end directed molecular motor cytoplasmic dynein is the key for understanding its complex cellular functions. LIS1-dynein interaction decreases the average velocity of the molecular motor in vitro, shows more complex effects in vivo, and may be of importance in high-load transport especially in neurons.
UR - http://www.scopus.com/inward/record.url?scp=84887410391&partnerID=8YFLogxK
U2 - 10.1016/j.conb.2013.08.001
DO - 10.1016/j.conb.2013.08.001
M3 - مقالة مرجعية
SN - 0959-4388
VL - 23
SP - 951
EP - 956
JO - Current Opinion in Neurobiology
JF - Current Opinion in Neurobiology
IS - 6
ER -